[
  {
    "chunk_id": 0,
    "text": "Malays J Pathol 2024; 46(3): 395 400 ORIGINAL ARTICLE MACB chronic kidney disease Task Force updated recommendations for reporting estimated glomerular estimated glomerular filtration rate and albuminuria in adults Pavai Sthaneshwar1, Leslie Charles Lai2, , Subashini C. Thambiah3, , Soo Kun Lim4, Ahmad Zulkely5, Low Yoke Lee6, Nafisah Mohamad Noor5, Peck Ham Chuo5, Sazaliah Ishak5, Siti Sharina Anas7, Siti Suhana Abdullah Soheimi5, Raja Elina Raja Aziddin8 1Department of Pathology, Faculty of Medicine, University Malaya; 2Gleneagles Hospital Kuala Lumpur; 3Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia; 4Department of Medicine, Faculty of Medicine, University Malaya; 5Department of Pathology, Hospital Kuala Lumpur; 6Premier Integrated Labs, Kuala Lumpur; 7Department of Pathology, Hospital Putrajaya; 8Malaysian Association of Clinical Biochemists Abstract Chronic Kidney disease (chronic kidney disease) is a common clinical condition with significant health risks for patients and is widely recognised as a major public health concern. Laboratory medicine plays a crucial role in both diagnosing and managing chronic kidney disease, as diagnosis and staging rely on estimated glomerular estimated glomerular filtration rate (glomerular filtration rate) and evaluating albuminuria (or proteinuria). It was evident that the laboratory assessment of chronic kidney disease in Malaysia is not standardised. In light of this, the Malaysian Association of Clinical Biochemistry chronic kidney disease (MACB-chronic kidney disease) Task Force issued a national recommendation for laboratory diagnosis of chronic kidney disease in 2019. Recently, Kidney Disease: Improving Global Outcomes (Kidney Disease: Improving Global Outcomes) updated its recommendations for the diagnosis, evaluation, management, and treatment of chronic kidney disease. These guidelines incorporate the most recent evidence-based practices to support laboratory professionals in delivering optimal care for individuals with chronic kidney disease, focusing on critical areas such as estimated glomerular filtration rate (estimated glomerular filtration rate), albuminuria assessment, and risk stratification. The latest National Institute for Health and Care Excellence (NICE) guidelines on chronic kidney disease has also incorporated the Kidney Failure Risk Equation (KFRE) as a tool for predicting the likelihood of progression to end-stage Kidney disease (end-stage kidney disease) in chronic kidney disease patients. Hence, the MACB-chronic kidney disease Task Force has reviewed and updated its recommendations for laboratory reporting of estimated glomerular filtration rate and Urine albumin in alignment with the latest guidelines. Keywords: chronic kidney disease, estimated glomerular filtration rate, albuminuria, KFRE INTRODUCTION The Kidney Disease: Improving Global Outcomes (Kidney Disease: Improving Global Outcomes) 2012 chronic kidney disease Clinical Chronic Kidney disease (chronic kidney disease) is a major Practice Guidelines (CPG)2 was built upon the global health issue, especially in Lowand foundational work of the United States-based middle-income countries, where it is associated Kidney Disease Outcomes Quality Initiative with serious health outcomes. 1 Since chronic kidney disease (Kidney Disease Outcomes Quality Initiative) 2002 CPG on the Definition, often advances without noticeable symptoms, Classification, and Evaluation of chronic kidney disease. 3 The clinicians depend on clinical laboratory results Kidney Disease Outcomes Quality Initiative 2002 CPG2 was subsequently embraced to diagnose, classify, treat, and monitor the by the international community in 2005, setting condition in patients. Laboratory medicine plays the stage for the development of the more a crucial role in diagnosing and managing chronic kidney disease. comprehensive Kidney Disease: Improving Global Outcomes 2012 CPG. The 2012 Diagnosis and staging are primarily determined CPG introduced the CGA classification system through estimated glomerular estimated glomerular filtration rate for chronic kidney disease, which categorises the disease based on (estimated glomerular filtration rate) and evaluation of albuminuria. three factors: cause (C), level of Kidney function Address for correspondence: Dr Pavai Sthaneshwar, Department of Pathology, Faculty of Medicine, University Malaya, 50603. Tel: 03-79492818 (PS); Email: pavaiummc.",
    "word_count": 597,
    "char_count": 4482,
    "sentence_count": 16,
    "metadata": {
      "source_file": "chronic-kidney-disease_2.pdf",
      "extraction_date": "2025-12-31T14:22:46.948519",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2024",
      "keywords": [
        "chronic kidney disease",
        "kidney function",
        "proteinuria",
        "albuminuria"
      ],
      "chunk_index": 0,
      "total_chunks": 7,
      "position": "1/7",
      "content_type": "monitoring",
      "content_type_confidence": 3,
      "medical_entities": [
        "chronic kidney disease",
        "glomerular filtration rate",
        "kidney function",
        "kidney failure",
        "albuminuria",
        "proteinuria",
        "classification"
      ],
      "entity_count": 7
    }
  },
  {
    "chunk_id": 1,
    "text": "Tel: 03-79492818 (PS); Email: pavaiummc. edu, my Leslie Charles Lai, Subashini C. Thambiah - contributed equally and are first coauthors 395 Malays J Pathol December 2024 as determined by glomerular estimated glomerular filtration rate (glomerular filtration rate) effective monitoring of chronic kidney disease by ensuring (G), and degree of albuminuria (A). This CGA that key markers, such as estimated glomerular filtration rate and classification provided a structured approach for albuminuria, are measured and reported the management, treatment, research, and risk consistently. assessment of chronic kidney disease, offering a comprehensive (v) Informed decision-making: Accurate framework that has since become the standard in and standardised laboratory results help the field. To address the adherence of Malaysian clinicians make informed decisions laboratories to the 2012 Kidney Disease: Improving Global Outcomes CPG on the about treatment plans, adjustments, and measurement and reporting of estimated glomerular filtration rate and Urine management strategies for chronic kidney disease patients. albumin, a national audit was conducted. This (vi) Quality control: Guidelines help maintain audit aimed to assess the current practices High-quality laboratory practices, reducing and identify any gaps or deviations from the the likelihood of errors and ensuring reliable CPG. Given the considerable heterogeneity results that support optimal patient care. observed among Malaysian laboratories in the By ensuring uniform presentation of survey results regarding biomarkers of Kidney results, clinicians can focus on the results damage, the Malaysian Association of Clinical rather than questioning discrepancies between Biochemists Chronic Kidney Disease (MACBlaboratories. The advantages of standardisation chronic kidney disease) Task Force developed recommendations become evident only with widespread adoption to standardise laboratory reporting of estimated by all laboratories. Achieving this requires glomerular filtration rate (estimated glomerular filtration rate) and Urine albumin4 which were collaboration among laboratories. Our main uploaded onto the MACB website on 20 goal was to provide recommendations that can November 2019. These recommendations were be easily applied in the laboratories in Malaysia. aligned with the Kidney Disease: Improving Global Outcomes 2012 CPG and the The following sections present recommendations National Institute for Health and Care Excellence specifically designed for implementation in the (NICE) guidelines. 5 The release of the Kidney Disease: Improving Global Outcomes clinical laboratory setting. 2024 chronic kidney disease CPG6 marks a significant update, replacing the 2012 version. This new CPG offers 1. Estimated glomerular estimated glomerular filtration rate and crucial guidance for healthcare professionals serum Creatinine on the evaluation and management of chronic kidney disease The Kidney Disease: Improving Global Outcomes 2024 chronic kidney disease CPG advises reporting and also the key recommendations for clinical serum Creatinine (serum creatinine) levels along with an laboratories. The MACB-chronic kidney disease Task Force held estimating equation as the initial approach a meeting in March 2024 to review and update to assess glomerular filtration rate. 6 The Kidney Disease: Improving Global Outcomes 2012 CPG recommendations on laboratory reporting of recommended reporting estimated glomerular filtration rate in adults using estimated glomerular filtration rate and Urine albumin based on Kidney Disease: Improving Global Outcomes the 2009 Chronic Kidney Disease Epidemiology 2024 and NICE 2022 guidelines. Standardising Collaboration (chronic kidney disease-EPI) Creatinine equation. laboratory reporting is intended to reduce However, an alternative Creatinine-based glomerular filtration rate confusion for laboratory users. estimating equation is considered acceptable if it has been demonstrated to enhance the accuracy Laboratory guidelines for chronic kidney disease are essential for of glomerular filtration rate estimates compared to the 2009 chronic kidney diseaseseveral reasons: EPI Creatinine equation. Estimating equations for (i) Consistency and accuracy: Guidelines glomerular filtration rate have traditionally included demographic ensure that tests are performed and results variables such as age, sex, and race.",
    "word_count": 597,
    "char_count": 4434,
    "sentence_count": 24,
    "metadata": {
      "source_file": "chronic-kidney-disease_2.pdf",
      "extraction_date": "2025-12-31T14:22:46.948519",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2024",
      "keywords": [
        "chronic kidney disease",
        "kidney function",
        "proteinuria",
        "albuminuria"
      ],
      "chunk_index": 1,
      "total_chunks": 7,
      "position": "2/7",
      "section": "Tel:",
      "content_type": "monitoring",
      "content_type_confidence": 5,
      "medical_entities": [
        "chronic kidney disease",
        "glomerular filtration rate",
        "albuminuria",
        "creatinine",
        "serum creatinine",
        "adherence",
        "monitoring",
        "classification"
      ],
      "entity_count": 8
    }
  },
  {
    "chunk_id": 2,
    "text": "These are reported consistently, improving the variables are incorporated into the equations to accuracy of chronic kidney disease diagnosis and management account for variations in serum concentrations across different laboratories. of endogenous filtration markers that are not (ii) Standardised care: By following established directly related to glomerular filtration rate. guidelines, laboratories can provide The inclusion of race in estimated glomerular filtration rate equations, standardised care, ensuring that patients as well as in other algorithms in medicine, has receive uniform diagnostic and monitoring faced growing scrutiny, especially in the United services regardless of location. States, but also in other parts of the world. (iii) Early detection and intervention: Incorporating race into medical algorithms Standardised testing and reporting enable may perpetuate racial biases and inequalities early detection of chronic kidney disease, which is crucial in healthcare and potentially lead to disparities for timely intervention and management. in diagnosis and treatment. Additionally, there (iv) Effective monitoring: Guidelines facilitate is concern that using race as a variable in 396 ROLE OF LABORATORY DIAGNOSIS AND MONITORING OF chronic kidney disease medical calculations may oversimplify complex 2. Urine albumin biological and social determinants of health. The In the Kidney Disease: Improving Global Outcomes 2012 CPG, the terminology concerns regarding the inclusion of race in glomerular filtration rate used was albuminuria rather than proteinuria estimating equations have prompted discussions as albumin is the principal component of and actions aimed at addressing this issue. One urinary Protein in most Kidney diseases. 2 The significant development has been the removal of MACB-chronic kidney disease Task Force also recommended the race coefficient from some glomerular filtration rate estimating the use of the term albuminuria rather than equations. 7 microalbuminuria. 4 The Kidney Disease: Improving Global Outcomes 2024 CPG In 2021, NICE recommended estimating recommends avoiding the use of Urine reagent Kidney function using the chronic kidney disease-EPI equation strips unless they can specifically measure Urine without ethnicity adjustments. Although the albumin at Low concentrations and express chronic kidney disease-EPI 2021 equation without ethnicity the result as Urine albumin-to-Creatinine ratio adjustment has been introduced, it has only (urine albumin-to-creatinine ratio) for identifying proteinuria in adults. been validated in North America. As a result, The descending order of preference for testing NICE still recommends using the chronic kidney disease-EPI of albuminuria is (i) urine albumin-to-creatinine ratio, or (ii) reagent 2009 equation. 8 The estimated glomerular filtration rate estimation by the strip urinalysis for albumin and albumin-creatinine ratio with new equation consistently showed a lower automated reading. A first-morning midstream prevalence of chronic kidney disease and higher glomerular filtration rate estimates Urine sample is preferred in all cases. When in Asian cohorts compared to the chronic kidney disease EPI measuring Urine Protein, the order of preference 2009 equation. 9 The 2009 chronic kidney disease-EPI Creatinine is: (i) Urine Protein-to-Creatinine ratio (urine protein-to-creatinine ratio), equation still performs well within recommended (ii) reagent strip urinalysis for total Protein with targets for estimating glomerular filtration rate in the non-Black automated reading, or (iii) reagent strip urinalysis race group, as measured by the percentage of for total Protein with manual reading. Urine eGFRs within 30% of measured glomerular filtration rate (mGFR), albumin measurement is a more sensitive and also known as P30. 8 The Kidney Disease: Improving Global Outcomes 2024 chronic kidney disease specific indicator of alterations in glomerular CPG recommends the use of the chronic kidney disease-EPI permeability compared to total urinary Protein equation within geographical regions without levels. 11 There are factors that can affect the Urine race correction but does not specify whether the albumin and Creatinine measurements.",
    "word_count": 594,
    "char_count": 4264,
    "sentence_count": 23,
    "metadata": {
      "source_file": "chronic-kidney-disease_2.pdf",
      "extraction_date": "2025-12-31T14:22:46.948519",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2024",
      "keywords": [
        "chronic kidney disease",
        "kidney function",
        "proteinuria",
        "albuminuria"
      ],
      "chunk_index": 2,
      "total_chunks": 7,
      "position": "3/7",
      "content_type": "recommendation",
      "content_type_confidence": 2,
      "medical_entities": [
        "chronic kidney disease",
        "glomerular filtration rate",
        "kidney function",
        "albuminuria",
        "proteinuria",
        "creatinine",
        "monitoring",
        "albumin-creatinine ratio"
      ],
      "entity_count": 8
    }
  },
  {
    "chunk_id": 3,
    "text": "When 2009 or 2021 equation should be used. 6 a random untimed Urine shows albuminuria, The laboratory plays a pivotal role in a repeat urine albumin-to-creatinine ratio on a first void morning Urine implementing the standards of care to ensure shall be done to confirm it. When urine albumin-to-creatinine ratio is 70 accuracy and reliability when measuring glomerular filtration rate magnesium/mmol or more, which is a sign of nephrotic using Creatinine. To ensure accurate measurement syndrome, urine protein-to-creatinine ratio can be an alternative measure of filtration markers, the laboratory should of proteinuria. 12 utilise a specific and precise assay with stringent It has also been recommended to implement performance criteria. Hence, the Kidney Disease: Improving Global Outcomes 2024 handling standards to ensure the accuracy and CPG advises the laboratory to use an assay reliability of findings when assessing Urine with a coefficient of variation (CV) less than samples. 6 Adoption of the reporting and handling 2. 3% for Creatinine and that the selected assay standards for the assessment of Urine samples demonstrates desirable bias less than 3. 7% is of paramount importance to ensure accurate compared with the reference methodology. 6 diagnoses, appropriate medical interventions, Meeting the suggested precision and bias targets and ultimately, better patient outcomes. ensures that laboratory errors have minimal To standardise the reporting format, it was impact, resulting in less than a 10% increase in recommended to report urine albumin-to-creatinine ratio as magnesium/mmol or root mean square error when estimating glomerular filtration rate. 6 magnesium/g and results should be expressed to one The recommendation emphasises the preference decimal place (magnesium/mmol) or whole numbers for utilising enzymatic methods, whenever (magnesium/g). The target analytical variation (CV) a feasible, for the measurement of Creatinine. should ideally be less than 0. 25 of the biological Enzymatic assays, while not entirely immune variation (CV), which is approximately 15%. 13 i to interferences, are generally more specific The new Kidney Disease: Improving Global Outcomes guideline also mentions that for Creatinine and less vulnerable to chemical point-of-care testing (POCT) for Creatinine and and chromogenic interferences like icterus and Urine albumin measurements can be utilised in haemolysis, thus reducing the likelihood of settings where access to a laboratory is limited. 6 interference in the majority of cases. 10 When employing POCT, it is advised to adhere to the same pre-analytical, analytical, and post397 Malays J Pathol December 2024 analytical quality criteria regarding specimen best performance in the original cohorts. 19 The collection, device performance, external quality 4-variable equation requires age, sex, estimated glomerular filtration rate, assessment, and result interpretation as for and urine albumin-to-creatinine ratio. This concise set of variables makes laboratory-based testing. it practical and straightforward, enabling automated risk reporting by the laboratory whenever 3. Kidney Failure Risk Equation laboratory tests are performed. The NICE chronic kidney disease The chronic kidney disease staging heatmaps illustrate relative guidelines also recommend using the UK fourrisks for each chronic kidney disease category compared to variable KFRE. 6 Hence, in line with NICE chronic kidney disease individuals without chronic kidney disease at a population level. guidelines, integrating 4-variable KFRE in the However, determining a persons absolute risk laboratory report helps clinicians in making for each outcome necessitates utilising risk informed decisions about patient management. prediction equations tailored to the specific KFRE can be reported as a 5-year risk and a adverse event. Individual-level risk prediction 2-year risk.",
    "word_count": 560,
    "char_count": 3918,
    "sentence_count": 27,
    "metadata": {
      "source_file": "chronic-kidney-disease_2.pdf",
      "extraction_date": "2025-12-31T14:22:46.948519",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2024",
      "keywords": [
        "chronic kidney disease",
        "kidney function",
        "proteinuria",
        "albuminuria"
      ],
      "chunk_index": 3,
      "total_chunks": 7,
      "position": "4/7",
      "content_type": "recommendation",
      "content_type_confidence": 5,
      "medical_entities": [
        "chronic kidney disease",
        "glomerular filtration rate",
        "kidney failure",
        "albuminuria",
        "proteinuria",
        "creatinine",
        "magnesium",
        "guideline"
      ],
      "entity_count": 8
    }
  },
  {
    "chunk_id": 4,
    "text": "Individual-level risk prediction 2-year risk. A 5-year Kidney failure risk assesscan significantly enhance key clinical decisions, ment can complement the criteria based on estimated glomerular filtration rate foster better patient-healthcare provider or urine albumin-to-creatinine ratio and other clinical considerations to communication, and facilitate personalised care determine the need for nephrology referral. 14 A for individuals with chronic kidney disease. 14 For individuals with 2-year Kidney failure risk can inform the timing chronic kidney disease stages G3G5, it is recommended to utilise of multidisciplinary care in addition to estimated glomerular filtration ratean externally validated risk equation to estimate based criteria. 14 the absolute risk of Kidney failure. 6 It is important Based on Kidney Disease: Improving Global Outcomes 2024 guidelines, the to note that risk prediction equations developed MACB-chronic kidney disease Task Force has updated their for individuals with chronic kidney disease stages G3G5 are recommendations to be adopted by the clinical not valid for use in those with chronic kidney disease stages laboratory as follows: G1G2. The recommendation also emphasises the importance of externally validated prediction Recommendations for laboratory reporting equations that are adaptable to diverse healthcare of estimated glomerular filtration rate: settings. Furthermore, it highlights the need for Pre-analytical implementing laboratory information systems 1. Separate serum/plasma from red Blood and electronic medical records to facilitate the cells by centrifugation within 12 hours of delivery of risk-based care for individuals with venepuncture. chronic kidney disease. This is a strong recommendation, as the Working Group has determined that the evidence Analytical supporting both the clinical validity and clinical 2. Enzymatic method for Creatinine assay shall utility of risk prediction equations was robust be used, where possible. enough to warrant widespread adoption. The 3. Creatinine measurement shall be traceable to three validated models are: The Kidney Failure isotope-dilution mass spectrometry (IDMS). Risk Equation (KFRE)15, the Veterans Affairs 4. The analytical imprecision of the Creatinine model16, and the Z6 Score model. 17 assay should be less than 2. 3% with a bias KFRE was developed and initially validated in of less than 3. 7% compared with reference 8, 391 adults from two Canadian provinces, and methodology or appropriate international subsequently validated in 721, 357 individuals standard reference method group target in from over 30 countries across four continents. 18 external quality assessment (EQA). In this extensive validation study, cohorts from both general populations and nephrology clinic Post-analytical settings were included, demonstrating excellent 5. Serum Creatinine concentration shall be discrimination with a C-statistic more than 0. 80 rounded to the nearest whole number when in 28 out of 30 cohorts. Four Kidney failure risk expressed in Âµmol/L. equations were developed in the original cohorts: 6. The chronic kidney disease-EPI 2009 equation shall be used the 3-variable equation (age, sex, and estimated glomerular filtration rate), in the calculation of estimated glomerular filtration rate without using the the 4-variable equation (3-variable plus urine albumin-to-creatinine ratio), race correction factor. the 6-variable equation (4-variable plus Diabetes 7. estimated glomerular filtration rate shall be rounded to the nearest whole mellitus and hypertension), and the 8-variable number and reported using the unit mL/ equation (4-variable plus calcium, phosphate, min/1. 73 m2. bicarbonate, and albumin). Among these, the 8. Clinical laboratories shall report estimated glomerular filtration rate as 4-variable and 8-variable equations showed the 90 milliliters per minute/1. 73 m2 if it is more than 90 milliliters per minute/1. 73 m2. 398 ROLE OF LABORATORY DIAGNOSIS AND MONITORING OF chronic kidney disease 9. estimated glomerular filtration rate levels less than 60 milliliters per minute/1.",
    "word_count": 583,
    "char_count": 4127,
    "sentence_count": 35,
    "metadata": {
      "source_file": "chronic-kidney-disease_2.pdf",
      "extraction_date": "2025-12-31T14:22:46.948519",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2024",
      "keywords": [
        "chronic kidney disease",
        "kidney function",
        "proteinuria",
        "albuminuria"
      ],
      "chunk_index": 4,
      "total_chunks": 7,
      "position": "5/7",
      "content_type": "recommendation",
      "content_type_confidence": 4,
      "medical_entities": [
        "chronic kidney disease",
        "glomerular filtration rate",
        "kidney failure",
        "creatinine",
        "calcium",
        "phosphate",
        "bicarbonate",
        "serum creatinine",
        "monitoring"
      ],
      "entity_count": 9
    }
  },
  {
    "chunk_id": 5,
    "text": "73 m2 9. urine albumin-to-creatinine ratio shall be reported to 1 decimal place shall be flagged as being Low. whether in magnesium/mmol or magnesium/g. 10. estimated glomerular filtration rate has to be interpreted with caution in people with extremes of muscle mass or REFERENCES certain illnesses (e. g. , bodybuilders, people 1. Kovesdy CP. Epidemiology of chronic Kidney who have had amputations, muscle wasting disease: an update 2022. Kidney Int Suppl (2011). disorders, acute myocardial infarction and 2022; 12: 7-11. acute Kidney injury). 2. Stevens physical examination, Levin A; Kidney Disease: Improving 11. Risk prediction equations developed for use Global Outcomes Chronic Kidney Disease Guideline in individuals with chronic kidney disease G3G5, are not Development Work Group Members. Evaluation and management of chronic Kidney disease: synopsis of valid for use in those with chronic kidney disease G1G2. the Kidney disease: improving global outcomes 2012 In people with chronic kidney disease G3G5, the laboratory clinical practice guideline. Ann Intern Med. 2013; shall use KFRE risk equation (4 variables) to 158: 825-30. estimate the absolute risk of Kidney failure 3. National Kidney Foundation. potassium/DOQI clinical and shall include practice guidelines for chronic Kidney disease: a. A 5-year Kidney failure risk (Low risk evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39 (Suppl 1): S1S266. 5% and High risk 15%) 4. P Sthaneshwar, L C Lai, R E Raja Azzidin, B and Mohd Hussain, S S Anas, et al. A national audit of b. A 2-year Kidney failure risk (Low risk estimated glomerular estimated glomerular filtration rate and proteinuria 10% and High risk 20%) and the MACD chronic kidney disease task force recommendations. Malays J Pathol. 2021; 43: 41-48. Recommendations for laboratory reporting 5. Clinical Guidelines on Chronic Kidney disease in of Urine albumin: adults: assessment and management. Published on 23 July 2014. nice. org. uk/guidance/cg182. Pre-analytical 6. Kidney Disease: Improving Global Outcomes 1. The first void Urine in the morning shall be (Kidney Disease: Improving Global Outcomes) chronic kidney disease Work Group. Kidney Disease: Improving Global Outcomes 2024 used for the measurement of urine albumin-to-creatinine ratio. Clinical Practice Guideline for the Evaluation and 2. Samples for Urine albumin measurement shall Management of Chronic Kidney Disease. Kidney not be stored at -20 oC. Int. 2024; 105: S117-S314. 3. Samples for Urine albumin measurement shall 7. Delgado C, Baweja M, Crews DC, et al. A unifying be analysed fresh or stored at 4 oC for up to approach for glomerular filtration rate estimation: recommendations of the National Kidney Foundation-American Society of Nephrology Task Force on Reassessing the 7 days. Inclusion of Race in Diagnosing Kidney Disease. Am J Kidney Dis 2022; 79: 268-288. Analytical 8. Clinical Guidelines on Chronic Kidney disease in 4. Urine reagent strips can only be used if they adults: assessment and management. Published on are capable of specifically measuring Urine 25 August 2021. albumin at Low concentrations and expressing ng203 the result as albumin: Creatinine ratio (urine albumin-to-creatinine ratio). 9. Betzler BK, Sultana R, He F, et al. Impact of Chronic 5. Analytical CV of methods to measure Urine Kidney Disease Epidemiology Collaboration (chronic kidney disease-EPI) glomerular filtration rate Estimating Equations on chronic kidney disease albumin shall be less than 15%. Prevalence and Classification Among Asians. Front Post-analytical Med (Lausanne). 2022; 9: 957437. 10. Myers GL, Miller WG, Coresh J, et al. 6. For the initial detection of proteinuria: Recommendations for improving serum Creatinine a. use urine albumin-to-creatinine ratio rather than urine protein-to-creatinine ratio because of measurement: a report from the Laboratory Working the greater sensitivity for Low levels of Group of the National Kidney Disease Education proteinuria. Program.",
    "word_count": 600,
    "char_count": 4018,
    "sentence_count": 61,
    "metadata": {
      "source_file": "chronic-kidney-disease_2.pdf",
      "extraction_date": "2025-12-31T14:22:46.948519",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2024",
      "keywords": [
        "chronic kidney disease",
        "kidney function",
        "proteinuria",
        "albuminuria"
      ],
      "chunk_index": 5,
      "total_chunks": 7,
      "position": "6/7",
      "content_type": "monitoring",
      "content_type_confidence": 3,
      "medical_entities": [
        "chronic kidney disease",
        "acute kidney injury",
        "glomerular filtration rate",
        "kidney failure",
        "proteinuria",
        "creatinine",
        "potassium",
        "magnesium",
        "serum creatinine",
        "guideline"
      ],
      "entity_count": 10
    }
  },
  {
    "chunk_id": 6,
    "text": "Program. Clin Chem. 2006; 52: 5-18. b. repeat urine albumin-to-creatinine ratio between 3 magnesium/mmol and 70 11. Lamb EJ, McTaggart MP, Stevens physical examination. Why magnesium/mmol in a subsequent early morning albumin to Creatinine ratio should replace Protein to Creatinine ratio: it is not just about nephrologists. sample to confirm the result. Annals of Clinical Biochemistry. 2013; 50: 301-305. c. A repeat sample is not needed if the initial 12. Evidence review for the accuracy of albumin: urine albumin-to-creatinine ratio is 70 magnesium/mmol or more. Creatinine ratio versus Protein Creatinine ratio 7. For quantification and monitoring of large measurements to quantify proteinuria in children and amounts of Urine Protein (more than 70 magnesium/ young people with chronic kidney disease: Chronic Kidney disease: mmol), urine protein-to-creatinine ratio may be used as an alternative. Evidence review B. London: National Institute for 8. If unexplained proteinuria is an incidental Health and Care Excellence (NICE); 2021 Aug. finding on a reagent strip, testing for chronic kidney disease (NICE Guideline, No. 203. ) Available from: https: // www. ncbi. nlm. nih. gov/books/NBK574716 using estimated glomerular filtration rate and urine albumin-to-creatinine ratio is recommended. 399 Malays J Pathol December 2024 13. Waikar SS, Rebholz CM, Zheng Z, Hurwitz S, Hsu CY et al. Chronic Kidney Disease Biomarkers Consortium Investigators. Biological Variability of Estimated glomerular filtration rate and Albuminuria in chronic kidney disease. Am J Kidney Dis. 2018; 72: 538 -546. 14. Rigatto C, Sood MM, Tangri N. Risk prediction in chronic Kidney disease: pitfalls and caveats. Curr Opin Nephrol Hypertens. 2012; 21: 612-618. 15. Grams ME, Brunskill NJ, Ballew social history, et al. The Kidney failure risk equation: evaluation of novel input variables including estimated glomerular filtration rate estimated using the chronic kidney disease-EPI 2021 equation in 59 cohorts. J Am Soc Nephrol. 2023; 34: 482-494. 16. Schroeder EB, Yang X, Thorp ML, et al. Predicting 5-year risk of RRT in stage 3 or 4 chronic kidney disease: development and external validation. Clin J Am Soc Nephrol. 2017; 12: 8794. 17. Zacharias HU, Altenbuchinger M, Schultheiss UT, et al. A predictive model for progression of chronic kidney disease to Kidney failure based on routine laboratory tests. Am J Kidney Dis. 2022; 79: 217230. e1. 18. Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic Kidney disease to Kidney failure. JAMA. 2011; 305: 15531559. 19. Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, et al; chronic kidney disease Prognosis Consortium. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Metaanalysis. JAMA. 2016 12; 315: 164-74. 400",
    "word_count": 433,
    "char_count": 2840,
    "sentence_count": 55,
    "metadata": {
      "source_file": "chronic-kidney-disease_2.pdf",
      "extraction_date": "2025-12-31T14:22:46.948519",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2024",
      "keywords": [
        "chronic kidney disease",
        "kidney function",
        "proteinuria",
        "albuminuria"
      ],
      "chunk_index": 6,
      "total_chunks": 7,
      "position": "7/7",
      "content_type": "monitoring",
      "content_type_confidence": 4,
      "medical_entities": [
        "chronic kidney disease",
        "glomerular filtration rate",
        "kidney failure",
        "albuminuria",
        "proteinuria",
        "creatinine",
        "magnesium",
        "monitoring",
        "stage 3",
        "guideline"
      ],
      "entity_count": 10
    }
  }
]